Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective Tinnitus

NCT00739635 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

411

Enrollment

INDUSTRY

Sponsor class

Conditions

Subjective Tinnitus

Interventions

DRUG: Neramexane mesylate
DRUG: Placebo

Sponsor

Merz Pharmaceuticals GmbH